摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-amino-2-(4-morpholinopiperidin-1-yl)benzonitrile | 288252-22-2

中文名称
——
中文别名
——
英文名称
5-amino-2-(4-morpholinopiperidin-1-yl)benzonitrile
英文别名
5-amino-2-(4-morpholin-4-ylpiperidin-1-yl)benzonitrile
5-amino-2-(4-morpholinopiperidin-1-yl)benzonitrile化学式
CAS
288252-22-2
化学式
C16H22N4O
mdl
——
分子量
286.377
InChiKey
HBFHFICPDPGDLM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    517.0±50.0 °C(Predicted)
  • 密度:
    1.23±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    65.5
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • PYRIDINE-3-CARBOXYAMIDE DERIVATIVE
    申请人:Kitamura Takahiro
    公开号:US20110237590A1
    公开(公告)日:2011-09-29
    To provide a novel JAK3 inhibitor that is useful as a preventive and/or therapeutic agent for rejection and graft versus host disease (GvHD) in organ transplantation, rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, Sjögren syndrome, Behcet's disease, type I diabetes mellitus, autoimmune thyroiditis, idiopathic thrombocytopenic purpura, ulcerative colitis, Crohn's disease, asthma, allergic rhinitis, atopic dermatitis, contact dermatitis, urticaria, eczema, psoriasis, allergic conjunctivitis, uveitis, cancer, leukemia and the like. The pyridine-3-carboxyamide derivative represented by the general formula (1): or its salt or a solvate thereof.
    提供一种新型JAK3抑制剂,可用作器官移植中的预防和/或治疗剂,以及风湿性关节炎、多发性硬化、系统性红斑狼疮、干燥综合征、贝赫切特病、I型糖尿病、自身免疫性甲状腺炎、特发性血小板减少性紫癜、溃疡性结肠炎、克罗恩病、哮喘、过敏性鼻炎、特应性皮炎、接触性皮炎、荨麻疹、湿疹、牛皮癣、过敏性结膜炎、葡萄膜炎、白血病等疾病的预防和治疗。通式(1)所代表的吡啶-3-羧酰胺衍生物: 或其盐或溶剂化合物。
  • [EN] HETEROCYCLYL COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS HÉTÉROCYCLYLIQUES ET LEURS UTILISATIONS
    申请人:PIRAMAL ENTPR LTD
    公开号:WO2014181287A1
    公开(公告)日:2014-11-13
    The present invention provides heterocyclyl compounds of formula I, isotopic forms, stereoisomers or tautomers thereof, or pharmaceutically acceptable salts, solvates, N- oxides, S-oxides and polymorphs thereof, and processes for their preparation. The invention further relates to pharmaceutical compositions containing the compounds and their use in the treatment of inflammatory diseases, autoimmune disorders and other related disorders. The heterocyclyl compounds find use as Interleukin 17 (IL-17) inhibitors and Tumor Necrosis Factor alpha (TNF-α) inhibitors.
    本发明提供了公式I的杂环化合物,其同位素形式、立体异构体或互变异构体,或其药学上可接受的盐、溶剂合物、N-氧化物、S-氧化物和多晶形式,以及其制备方法。该发明还涉及含有这些化合物的药物组合物,以及它们在治疗炎症性疾病、自身免疫性疾病和其他相关疾病中的用途。这些杂环化合物可用作白细胞介素17(IL-17)抑制剂和肿瘤坏死因子α(TNF-α)抑制剂。
  • Fused bicyclic amide compounds and medicinal use thereof
    申请人:——
    公开号:US20030203909A1
    公开(公告)日:2003-10-30
    The present invention provides a compound represented by the formula (I) 1 wherein ring A is benzene, cyclohexane, pyridine, piperidine or a derivative thereof, imidazole or a derivative thereof and the like, ring B is benzene, cyclohexane, pyrrole or a derivative thereof, furan, thiophene and the like, R 1 , R 2 and R 3 are each hydrogen, alkyl, halogen, hydroxyl group, alkoxy and the like, W is hydrogen, alkyl or hydroxycarbonylalkyl, X is halogen, cyano, nitro and the like, X′ is hydrogen, halogen and the like, and Y is alkyl, hydroxyalkyl, hydroxycarbonylalkyl, aminoalkyl and the like, a salt thereof, and a pharmaceutical agent containing the compound. The compound of the present invention shows a superior inhibitory effect on the proliferation of activated lymphocyte and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.
    本发明提供了一种由以下化学式(I)1所代表的化合物,其中环A为苯、环己烷、吡啶、哌啶或其衍生物、咪唑或其衍生物等,环B为苯、环己烷、吡咯或其衍生物、呋喃、噻吩等,R1、R2和R3分别为氢、烷基、卤素、羟基、烷氧基等,W为氢、烷基或羟基羰基烷基,X为卤素、氰基、硝基等,X′为氢、卤素等,Y为烷基、羟基烷基、羟基羰基烷基、氨基烷基等,其盐和含有该化合物的药物。本发明的化合物对活化淋巴细胞的增殖具有优越的抑制作用,并可用作各种自身免疫性疾病的预防或治疗剂。
  • Amide compounds and medicinal use thereof
    申请人:Mitsubishi Pharma Corporation
    公开号:US07015218B1
    公开(公告)日:2006-03-21
    The present invention relates to a compound of the formula wherein R1 is substituted aryl, heteroaryl and the like, R2 and R3 are hydrogen, alkyl, halogen, hydroxyl group and the like, Q is N, CH and the like, W is hydrogen, alkyl, hydroxycarbonylalkyl and the like, X is halogen, cyano, nitro, amino and the like, X′ is hydrogen, halogen, cyano, nitro, and Y is alkyl, hydroxyl group, alkoxy, mercapto and the like and a salt thereof, and a medicine containing the said compound. The compound of the present invention shows a superior inhibitory effect on activated lymphocytes proliferation and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.
    本发明涉及一种化合物,其化学式为其中R1为取代芳基,杂环芳基等,R2和R3为氢,烷基,卤素,羟基等,Q为N,CH等,W为氢,烷基,羟基羧基烷基等,X为卤素,氰基,硝基,氨基等,X'为氢,卤素,氰基,硝基,Y为烷基,羟基,烷氧基,巯基等及其盐,以及包含所述化合物的药物。本发明的化合物显示出对活化淋巴细胞增殖的优越抑制作用,并可用作各种自身免疫性疾病的预防或治疗剂。
  • FUSED BICYCLIC AMIDE COMPOUNDS AND MEDICINAL USE THEREOF
    申请人:Mitsubishi Pharma Corporation
    公开号:EP1310488A1
    公开(公告)日:2003-05-14
    The present invention provides a compound represented by the formula (I) wherein ring A is benzene, cyclohexane, pyridine, piperidine or a derivative thereof, imidazole or a derivative thereof and the like, ring B is benzene, cyclohexane, pyrrole or a derivative thereof, furan, thiophene and the like, R1, R2 and R3 are each hydrogen, alkyl, halogen, hydroxyl group, alkoxy and the like, W is hydrogen, alkyl or hydroxycarbonylalkyl, X is halogen, cyano, nitro and the like, X' is hydrogen, halogen and the like, and Y is alkyl, hydroxyalkyl, hydroxycarbonylalkyl, aminoalkyl and the like, a salt thereof, and a pharmaceutical agent containing the compound. The compound of the present invention shows a superior inhibitory effect on the proliferation of activated lymphocyte and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.
    本发明提供了一种由式(I)表示的化合物 其中环 A 是苯、环己烷、吡啶、哌啶或其衍生物、咪唑或其衍生物等,环 B 是苯、环己烷、吡咯或其衍生物、呋喃、噻吩等,R1、R2 和 R3 分别是氢、烷基、卤素、羟基、烷氧基等,W 是氢、烷基或羟基羰基烷基,X 是卤素、氰基、硝基等、W为氢、烷基或羟基羰基烷基,X为卤素、氰基、硝基等,X'为氢、卤素等,Y为烷基、羟基烷基、羟基羰基烷基、氨基烷基等,其盐以及含有该化合物的药剂。本发明的化合物对活化淋巴细胞的增殖有很好的抑制作用,可作为预防或治疗各种自身免疫性疾病的药物。
查看更多